125 related articles for article (PubMed ID: 1632074)
21. Rabbit monoclonal antibodies: generating a fusion partner to produce rabbit-rabbit hybridomas.
Spieker-Polet H; Sethupathi P; Yam PC; Knight KL
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9348-52. PubMed ID: 7568130
[TBL] [Abstract][Full Text] [Related]
22. Generation by self re-fusion of bovine³ × murine² heterohybridomas secreting virus-neutralizing bovine monoclonal antibodies to bovine herpesvirus 1 glycoproteins gB, gC, and gD.
Levings RL; Stoll IR; Warg JV; Patterson PA; Hobbs LA; Kaeberle ML; Roth JA
Vet Immunol Immunopathol; 2014 May; 159(1-2):58-73. PubMed ID: 24629764
[TBL] [Abstract][Full Text] [Related]
23. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
Cote RJ; Morrissey DM; Oettgen HF; Old LJ
Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
[TBL] [Abstract][Full Text] [Related]
24. Preparation of human-mouse heterohybridomas against an immunising antigen.
Jessup CF; Baxendale H; Goldblatt D; Zola H
J Immunol Methods; 2000 Dec; 246(1-2):187-202. PubMed ID: 11121559
[TBL] [Abstract][Full Text] [Related]
25. Characterization of mouse-human hybridoma as a useful fusion partner for the establishment of mouse-human-human hybridoma secreting anti-tetanus toxoid human monoclonal antibody of IgM or IgG class.
Hirata Y; Sugawara I
Microbiol Immunol; 1987; 31(3):231-45. PubMed ID: 3613992
[TBL] [Abstract][Full Text] [Related]
26. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.
Crouch CF; Daly J; Hannant D; Wilkins J; Francis MJ
Vaccine; 2004 Dec; 23(3):418-25. PubMed ID: 15530689
[TBL] [Abstract][Full Text] [Related]
27. High efficiency creation of human monoclonal antibody-producing hybridomas.
Dessain SK; Adekar SP; Stevens JB; Carpenter KA; Skorski ML; Barnoski BL; Goldsby RA; Weinberg RA
J Immunol Methods; 2004 Aug; 291(1-2):109-22. PubMed ID: 15345310
[TBL] [Abstract][Full Text] [Related]
28. The effects of hybridoma growth factor in conditioned media upon the growth, cloning, and antibody production of heterohybridoma cell lines.
Zhu Y; Jin B; Sun C; Huang C; Liu X
Hum Antibodies Hybridomas; 1993 Jan; 4(1):31-5. PubMed ID: 8431556
[TBL] [Abstract][Full Text] [Related]
29. Characterization of an established mouse-human heterohybridoma and its application for production of (mouse-human)-human triple hybridoma secreting human immunoglobulin.
Sugiyama M; Goto S; Saito M; Sonta S; Mizuno K; Furuhashi Y; Nagoya T; Tomoda Y
Hybridoma; 1991 Feb; 10(1):11-9. PubMed ID: 2032730
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of immunosuppressants and antibiotics on human monoclonal antibody production in SCID mouse ascites by five heterohybridomas.
Yoshinari K; Arai K
Hybridoma; 1998 Feb; 17(1):41-5. PubMed ID: 9523236
[TBL] [Abstract][Full Text] [Related]
31. Use of heterohybridomas in xenotransplantation.
Yang Q; Bollinger RR; De Buysscher EV
Transplant Proc; 1992 Apr; 24(2):457-8. PubMed ID: 1566389
[No Abstract] [Full Text] [Related]
32. Specific bovine monoclonal antibody produced by a re-fused mouse/calf hybridoma.
Tucker EM; Dain AR; Clarke SW; Donker RA
Hybridoma; 1984; 3(2):171-6. PubMed ID: 6480023
[TBL] [Abstract][Full Text] [Related]
33. Determination of the optimal human cell lines for development of human hybridomas.
Abrams PG; Knost JA; Clarke G; Wilburn S; Oldham RK; Foon KA
J Immunol; 1983 Sep; 131(3):1201-4. PubMed ID: 6350451
[TBL] [Abstract][Full Text] [Related]
34. Antibody producing human-human hybridomas. I. Technical aspects.
Olsson L; Kronstrøm H; Cambon-De Mouzon A; Honsik C; Brodin T; Jakobsen B
J Immunol Methods; 1983 Jun; 61(1):17-32. PubMed ID: 6343505
[TBL] [Abstract][Full Text] [Related]
35. Hybridoma Technology.
Hnasko RM; Stanker LH
Methods Mol Biol; 2015; 1318():15-28. PubMed ID: 26160560
[TBL] [Abstract][Full Text] [Related]
36. Human monoclonal anti-D secreting heterohybridomas from peripheral B lymphocytes expanded in the CD40 system.
Thompson JM; Lowe J; McDonald DF
J Immunol Methods; 1994 Sep; 175(1):137-40. PubMed ID: 7523524
[TBL] [Abstract][Full Text] [Related]
37. Establishment of human Ig producing heterohybridomas by fusion of mouse myeloma cells with human lymphocytes derived from peripheral blood, bone marrow, spleen, lymph node, and synovial fluid. Effect of polyclonal prestimulation and cryopreservation.
Jahn S; Grunow R; Kiessig ST; Specht U; Matthes H; Hiepe F; Hlinak A; Von Baehr R
J Immunol Methods; 1988 Feb; 107(1):59-66. PubMed ID: 3343518
[TBL] [Abstract][Full Text] [Related]
38. Studies with inactivated equine influenza vaccine. 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8).
Mumford J; Wood JM; Scott AM; Folkers C; Schild GC
J Hyg (Lond); 1983 Jun; 90(3):385-95. PubMed ID: 6306098
[TBL] [Abstract][Full Text] [Related]
39. A porcine-murine hybridoma that secretes porcine monoclonal antibody of defined specificity.
Raybould TJ; Willson PJ; McDougall LJ; Watts TC
Am J Vet Res; 1985 Aug; 46(8):1768-9. PubMed ID: 3898933
[TBL] [Abstract][Full Text] [Related]
40. Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma.
Houghton AN; Brooks H; Cote RJ; Taormina MC; Oettgen HF; Old LJ
J Exp Med; 1983 Jul; 158(1):53-65. PubMed ID: 6864164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
